Literature DB >> 32130518

High glucose concentration produces a short-term increase in pERK1/2 and p85 proteins, having a direct angiogenetic effect by an action similar to VEGF.

Candida Zuchegna1, Ferdinando Carlo Sasso2, Mario Felice Tecce3, Anna Capasso3, Luigi Elio Adinolfi4, Antonella Romano5, Silvia Bartollino6, Antonio Porcellini5, Ciro Costagliola6.   

Abstract

AIMS: Excessive glucose serum concentration, endothelial dysfunction and microangiopathy are key features of diabetes mellitus, being both diagnostic parameters and pathogenetic mechanisms. Vascular endothelial growth factor (VEGF) is importantly implicated in the physiology and pathology of blood vessels, including diabetic vascular damage.
METHODS: These factors certainly affect endothelial cells, and to evaluate mechanisms involved, we took advantage of telomerase-immortalized human microvascular endothelial (TIME) cells. TIME cells were exposed to different glucose concentrations and to VEGF treatments. Culture conditions also included the use of basement membrane extract, as an in vitro differentiation model. Cell morphology was then evaluated in the different conditions, and cellular proteins were extracted to analyze specific protein products by Western blot.
RESULTS: High glucose concentrations and VEGF did substantially affect neither morphology nor growth of cultured TIME cells, while both considerably increased differentiation into "capillary-like" structures when cells were cultured on basement membrane extract.
CONCLUSIONS: Under these conditions, high glucose concentration and VEGF also produced a short-term increase in pERK1/2 and p85 proteins, while total and phosphorylated AKT were not affected. These data suggest a direct angiogenetic effect of glucose, affecting intracellular transduction mechanisms with an action similar to that of VEGF. This effect on endothelial cell proliferation and differentiation could be part of pathogenetic mechanisms producing diabetic microvascular alterations.

Entities:  

Keywords:  Diabetes; Endothelial differentiation; Glucose; Hyperglycemia; VEGF

Mesh:

Substances:

Year:  2020        PMID: 32130518     DOI: 10.1007/s00592-020-01501-z

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  34 in total

Review 1.  Erythropoietin and microvascular diabetic complications.

Authors:  Kai-Uwe Eckardt
Journal:  Nephrol Dial Transplant       Date:  2008-10-24       Impact factor: 5.992

Review 2.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

3.  Angiopoietin concentrations in diabetic retinopathy.

Authors:  J I Patel; P G Hykin; Z J Gregor; M Boulton; I A Cree
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells.

Authors:  Eleni Venetsanakos; Amer Mirza; Christie Fanton; Serguei R Romanov; Thea Tlsty; Martin McMahon
Journal:  Exp Cell Res       Date:  2002-02-01       Impact factor: 3.905

5.  Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.

Authors:  Angela Coxon; James Bready; Hosung Min; Stephen Kaufman; Juan Leal; Dongyin Yu; Tani Ann Lee; Ji-Rong Sun; Juan Estrada; Brad Bolon; James McCabe; Ling Wang; Karen Rex; Sean Caenepeel; Paul Hughes; David Cordover; Haejin Kim; Seog Joon Han; Mark L Michaels; Eric Hsu; Grant Shimamoto; Russell Cattley; Eunju Hurh; Linh Nguyen; Shao Xiong Wang; Anthony Ndifor; Isaac J Hayward; Beverly L Falcón; Donald M McDonald; Luke Li; Tom Boone; Richard Kendall; Robert Radinsky; Jonathan D Oliner
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

Review 6.  Vascular endothelial growth factor signaling in development and disease.

Authors:  Sinem Karaman; Veli-Matti Leppänen; Kari Alitalo
Journal:  Development       Date:  2018-07-20       Impact factor: 6.868

Review 7.  Vascular endothelial growth factor and diabetic complications.

Authors:  Barbara Wirostko; Tien Y Wong; Rafael Simó
Journal:  Prog Retin Eye Res       Date:  2008-10-01       Impact factor: 21.198

8.  Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.

Authors:  Virginia Haurigot; Pilar Villacampa; Albert Ribera; Cristina Llombart; Assumpcio Bosch; Victor Nacher; David Ramos; Eduard Ayuso; José C Segovia; Juan A Bueren; Jesus Ruberte; Fatima Bosch
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  2 in total

1.  Anti-inflammatory Effect of Curcumin, Homotaurine, and Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy.

Authors:  Mariaelena Filippelli; Giuseppe Campagna; Pasquale Vito; Tiziana Zotti; Luca Ventre; Michele Rinaldi; Silvia Bartollino; Roberto dell'Omo; Ciro Costagliola
Journal:  Front Neurol       Date:  2021-02-05       Impact factor: 4.003

2.  Effect of a Fixed Combination of Curcumin, Artemisia, Bromelain, and Black Pepper Oral Administration on Optical Coherence Tomography Angiography Indices in Patients with Diabetic Macular Edema.

Authors:  Flavia Chiosi; Michele Rinaldi; Giuseppe Campagna; Gianluigi Manzi; Vincenzo De Angelis; Francesco Calabrò; Luca D'Andrea; Fausto Tranfa; Ciro Costagliola
Journal:  Nutrients       Date:  2022-04-06       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.